Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shadick

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|February 12, 1998
Feasibility and utility of adding disease-specific outcome measures to administrative databases to improve disease managementM H Liang, N Shadick
Arthritis and Rheumatism|May 16, 2001
Leflunomide-associated weight loss in rheumatoid arthritisJ S Coblyn, N Shadick, S Helfgott
Journal of the American Geriatrics Society|July 1, 1987
Low serum B12 levels in a hematologically normal elderly subpopulationD L Marcus, N Shadick, J Crantz, et al.
Clinical Immunology and Immunopathology|January 1, 1988
Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosusJ P Buyon, N Shadick, R Berkman, et al.
Rheumatology (Oxford, England)|March 22, 2008
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexateM Vera-Llonch, E Massarotti, F Wolfe, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|February 12, 1998
Feasibility and utility of adding disease-specific outcome measures to administrative databases to improve disease managementM H Liang, N Shadick
Arthritis and Rheumatism|May 16, 2001
Leflunomide-associated weight loss in rheumatoid arthritisJ S Coblyn, N Shadick, S Helfgott
Journal of the American Geriatrics Society|July 1, 1987
Low serum B12 levels in a hematologically normal elderly subpopulationD L Marcus, N Shadick, J Crantz, et al.
Clinical Immunology and Immunopathology|January 1, 1988
Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosusJ P Buyon, N Shadick, R Berkman, et al.
Rheumatology (Oxford, England)|March 22, 2008
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexateM Vera-Llonch, E Massarotti, F Wolfe, et al.
Pageof 1